Raymond James price target raised to $194 from $173 at BofA

Published 23/10/2025, 19:42
Raymond James price target raised to $194 from $173 at BofA

Investing.com - BofA Securities has increased its price target on Raymond James (NYSE:RJF) to $194.00 from $173.00 while maintaining a Neutral rating on the stock. According to InvestingPro data, the company appears undervalued at its current price of $165, with 8 analysts recently revising their earnings expectations upward.

The adjustment follows Raymond James reporting earnings per share of $3.11 on Wednesday, significantly exceeding the consensus estimate of $2.84. The earnings beat was primarily driven by strong brokerage and investment banking revenues, along with a lower tax rate. The company maintains robust financial health with an impressive current ratio of 6.53 and has shown consistent revenue growth of 11.8% over the last twelve months.

Raymond James posted net new assets (NNAs) at an annualized rate of 5%, showing sequential improvement from 3.4% in the previous quarter. The growth came across all three of the company’s channels: employee, independent, and registered investment advisor (RIA).

While management expressed optimism about future organic growth, BofA Securities noted that the strength in net new assets was partially due to disruptions in the financial advisor space from mergers and acquisitions and consolidation, which the firm considers "partly unsustainable."

BofA Securities also highlighted that Raymond James is projected to lose approximately $3 billion in assets under custody in the first quarter of fiscal year 2026 due to bank mergers and acquisitions.

In other recent news, Raymond James Financial Inc. reported impressive fourth-quarter earnings for fiscal year 2025, surpassing analyst expectations. The company achieved an adjusted earnings per share (EPS) of $3.11, exceeding the forecasted $2.82, and reported revenue of $3.73 billion against an expected $3.64 billion. Following these strong results, several firms adjusted their price targets for Raymond James. Keefe, Bruyette & Woods raised its price target to $181 from $174, maintaining a Market Perform rating, while BMO Capital increased its target to $182 from $180, also with a Market Perform rating. Citizens raised its price target even further to $190, citing a positive growth outlook and maintaining a Market Outperform rating. Citizens also adjusted its fiscal year 2026 earnings per share estimate to $12.55, positioning it 7% above the current consensus estimate. These developments reflect the company’s robust performance and optimistic projections for future growth.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.